A study presented at ENDO 2022 in Atlanta this past summer suggests that active testosterone therapy for transgender men may negatively impact IVF outcomes. Research presented by Amanda Schwartz, MD, a reproductive endocrinology and infertility fellow at the University of Michigan, found that female mice currently receiving testosterone had fewer and less developed eggs retrieved....
As transgender medical care becomes unfairly politicized, presentations such as ENDO 2022’s Meet the Professor session “Beginner’s Guide to Gender-Affirming Hormone Therapy for Transgender and Gender Diverse Adults” are more essential than ever. Attendees will be shown a variety of best practices in providing affirming care to transgender and gender diverse adults. On the...
Misinformation disregards science and restricts access to evidence-based care. The Endocrine Society objects to the Florida Department of Health’s bulletin on gender-affirming care for transgender and gender-diverse youth. The bulletin contradicts the U.S. Department of Health & Human Services’ resources and the Society’s own evidence-based Clinical Practice Guideline regarding gender-affirming care. We call on the Florida Department...
Texas governor inaccurately characterizes evidence-based care as “child abuse.“ The Endocrine Society condemns the directive by Texas Governor Greg Abbott ordering the Department of Family and Protective Services (DFPS) to investigate any reported instances of Texas children receiving gender-affirming care as “child abuse.” This policy rejects evidence-based transgender medical care and will restrict access to...
New research published in The Journal of Clinical Endocrinology & Metabolism shows that transgender women may be at higher risk for type 2 diabetes compared to cisgender women, but not to cisgender men. However, there is little evidence that hormone therapy is the culprit. As of 2016, 1.4 million adults identify as transgender or gender...
Transgender women may be at higher risk for type 2 diabetes compared to cisgender women, but not to cisgender men, according to new research published in The Journal of Clinical Endocrinology & Metabolism. Nearly 1 million people identify as transgender in the U.S., and healthcare providers are encountering more transgender and gender-diverse patients in their practices. An important priority of transgender health research is to...
As transgender medical care becomes unfairly politicized, presentations such as ENDO 2022’s Meet the Professor session “Beginner’s Guide to Gender-Affirming Hormone Therapy for Transgender and Gender Diverse Adults” are more essential than ever. Attendees will be shown a variety of best practices in providing affirming care to transgender and gender diverse adults. On the...
Transgender women may be at higher risk for type 2 diabetes compared to cisgender women, but not to cisgender men, according to new research published in The Journal of Clinical Endocrinology & Metabolism. Nearly 1 million people identify as transgender in the U.S., and healthcare providers are encountering more transgender and gender-diverse patients in their practices. An important priority of transgender health research is to...
